Status:
COMPLETED
PALUREA: Severe Imported Malaria in Adults
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Malaria
Eligibility:
All Genders
18+ years
Brief Summary
Plasmodium falciparum malaria remains a major public health problem in endemic areas, with approximately 2 million deaths each year, especially in tropical African countries. In non-endemic industria...
Detailed Description
Plasmodium falciparum malaria remains a major public health problem in endemic areas, with approximately 2 million deaths each year, especially in tropical African countries. In non-endemic industria...
Eligibility Criteria
Inclusion
- Inclusion Criteria in Severe Malaria Group:
- Hospitalization in the ICU and
- Presence of asexual forms of Plasmodium falciparum in the blood and
- One or more severe manifestations according to the World Health Organization (WHO) definition of severe falciparum malaria published in 2000
- Inclusion Criteria in Uncomplicated Malaria Group:
- Hospitalization in Medicine unit or ambulatory and
- Presence of asexual forms of Plasmodium falciparum in the blood and
- Absence of any severe manifestation according to the WHO definition of severe falciparum malaria published in 2000 with the exception of the criteria hyper parasitaemia (superior4%) when isolated or the criteria jaundice /total bilirubin superior 5 micromol/L when isolated
Exclusion
- Patient \< 18 years-old
- Impossible to obtain informed consent
- Curative treatment of malaria for more than 72 hours
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT00372684
Start Date
September 1 2006
End Date
March 1 2010
Last Update
June 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ch Versailles
Le Chesnay, France, 78150